Carrotee Ivergurad Tablet
NDC Package 87722-251-01

11-digit billing NDC: 87722025101
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Carrotee Ivergurad (pyrantel pamoate) tablets is treats pinworms (enterobiasis). This formulation utilizes a tablet delivery system. Marketed by Guangdong Jiaoyu Biotechnology Co., Ltd, this product is identified by NDC 87722-251 and is authorized under FDA application M024.

Identification & Billing

NDC Package Code
87722-251-01
Package Description
1200 mg in 1 BOTTLE
Product Code
87722-251
11-Digit Billing Format
87722025101

Clinical Specifications

Proprietary Name
Carrotee Ivergurad
Non-Proprietary Name
Pyrantel Pamoate
Substance Name
Pyrantel Pamoate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
PYRANTEL PAMOATE 12 mg/100mg
Usage Information
Treats pinworms (enterobiasis)

Regulatory & Marketing

Labeler Name
Guangdong Jiaoyu Biotechnology Co., Ltd
Product Type
Human Otc Drug
FDA Application #
M024
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-08-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87722-251-01 identifies a specific commercial package of 1200 mg in 1 bottle of Carrotee Ivergurad, a human over the counter drug labeled by Guangdong Jiaoyu Biotechnology Co., Ltd. This tablet is formulated for oral use and contains pyrantel pamoate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangdong Jiaoyu Biotechnology Co., Ltd on October 08, 2026. The current certification is valid through December 31, 2027.

How is this Guangdong Jiaoyu Biotechnology Co., Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87722025101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87722-251-01
11-Digit CMS (5-4-2)
87722-0251-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.